Masimo Corporation

Equities

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-28 pm EDT 5-day change 1st Jan Change
127.2 USD +0.14% Intraday chart for Masimo Corporation +2.14% +8.51%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Some of the biggest splits in Corporate America RE
Masimo and Denon Introduces White PerL and PerL Pro? Earbuds CI
Transcript : Masimo Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 04:20 PM
Craig Reynolds Sends the Letter to Quentin Koffey of Politan Capital CI
Masimo says prepared to provide one board seat to activist investor Politan RE
Masimo Corporation Craig Reynolds Sends a Letter to Politan Capital's Quentin Koffey CI
Politan Capital's Quentin Koffey Sends A Letter to Masimo Corporation CEO Joe Kiani CI
Politan Capital Management Threatens Masimo Corporation with Legal Action CI
Sector Update: Health Care Stocks Softer Late Afternoon MT
Sector Update: Health Care MT
Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set; Shares Fall MT
Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set -- Shares Rise After Hours MT
Masimo Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024 CI
(MASI) MASIMO CORPORATION Forecasts Q2 Revenue Range $480M - $510M MT
(MASI) MASIMO CORPORATION Forecasts Fiscal Year 2024 EPS Range $3.54 - $3.70 MT
Earnings Flash (MASI) MASIMO CORPORATION Reports Q1 Revenue $492.8M, vs. Street Est of $487.7M MT
Transcript : Masimo Corporation, Q1 2024 Earnings Call, May 07, 2024
Masimo Corporation Provides Earnings Guidance for the Second Quarter 2024 and Updates Earnings Guidance for the Full-Year 2024 CI
Masimo Obtains FDA Clearance for Over-The-Counter Version of Stork Baby Monitoring System MT
Masimo Receives FDA Clearance for Stork Over-the-Counter Baby Monitoring System CI
Masimo Insider Sold Shares Worth $5,446,616, According to a Recent SEC Filing MT
Stifel Upgrades Masimo to Buy From Hold, Raises Price Target to $170 From $148 MT
Apple to Allow Other Payment Options for Music Apps in Europe; Appeals to Overturn Apple Watch Import Ban MT
Apple asks US appeals court to reverse Apple Watch import ban RE
Masimo Responds to Claims by Shareholder Activist Politan Capital MT
Chart Masimo Corporation
More charts
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
127.2 USD
Average target price
151.9 USD
Spread / Average Target
+19.43%
Consensus
  1. Stock Market
  2. Equities
  3. MASI Stock
  4. News Masimo Corporation
  5. Wells Fargo Upgrades Masimo to Overweight From Equalweight, Adjusts Price Target to $160 From $117